Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07239739Not yet recruiting
Randomised trial of metronidazole + ciprofloxacin + minocycline in periapical periodontitis (AP) and Periapical lesion (AP) (2 arms). Primary endpoint: Change in Periapical Lesion Area at 12 months. Planned start Jun 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07239739.